(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 1.34% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Solventum's revenue in 2025 is $8,254,000,000.On average, 3 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,427,941,523,171, with the lowest SOLV revenue forecast at $1,424,749,675,640, and the highest SOLV revenue forecast at $1,431,730,706,864. On average, 3 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,452,513,611,342, with the lowest SOLV revenue forecast at $1,430,112,380,830, and the highest SOLV revenue forecast at $1,477,249,175,526.
In 2027, SOLV is forecast to generate $1,487,975,450,859 in revenue, with the lowest revenue forecast at $1,450,006,287,180 and the highest revenue forecast at $1,528,278,083,257.